{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T01:12:20Z","timestamp":1780362740172,"version":"3.54.1"},"reference-count":28,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.3892\/ol.2012.1001","type":"journal-article","created":{"date-parts":[[2012,10,26]],"date-time":"2012-10-26T10:32:27Z","timestamp":1351247547000},"page":"191-197","source":"Crossref","is-referenced-by-count":60,"title":["Carbonic anhydrase IX is a clinically significant tissue and serum biomarker associated with renal cell carcinoma"],"prefix":"10.3892","volume":"5","author":[{"given":"MARTINA","family":"TAKACOVA","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MARIA","family":"BARTOSOVA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LUCIA","family":"SKVARKOVA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MIRIAM","family":"ZATOVICOVA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"IVANA","family":"VIDLICKOVA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LUCIA","family":"CSADEROVA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MONIKA","family":"BARATHOVA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"JAN","family":"BREZA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PETER","family":"BUJDAK","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JAROMIR","family":"PASTOREK","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Sr","given":"JAN","family":"BREZA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SILVIA","family":"PASTOREKOVA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2012,10,26]]},"reference":[{"key":"key20180108093016_b1-ol-05-01-0191","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3322\/caac.20073","article-title":"Cancer statistics, 2010","volume":"60","author":"Jemal","year":"2010","journal-title":"CA Cancer J Clin"},{"key":"key20180108093016_b2-ol-05-01-0191","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/ng0594-85","article-title":"Mutations of the VHL tumour suppressor gene in renal carcinoma","volume":"7","author":"Gnarra","year":"1994","journal-title":"Nat Genet"},{"key":"key20180108093016_b3-ol-05-01-0191","first-page":"7075","article-title":"Hypoxia-inducible expression of tumor-associated carbonic anhydrases","volume":"60","author":"Wykoff","year":"2000","journal-title":"Cancer Res"},{"key":"key20180108093016_b4-ol-05-01-0191","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.febslet.2004.10.043","article-title":"Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH","volume":"577","author":"Svastova","year":"2004","journal-title":"FEBS Lett"},{"key":"key20180108093016_b5-ol-05-01-0191","first-page":"802","article-title":"Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy","volume":"9","author":"Bui","year":"2003","journal-title":"Clin Cancer Res"},{"key":"key20180108093016_b6-ol-05-01-0191","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/0042-6822(92)90464-Z","article-title":"A novel quasi-viral agent, MaTu, is a two-component system","volume":"187","author":"Pastorekova","year":"1992","journal-title":"Virology"},{"key":"key20180108093016_b7-ol-05-01-0191","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jim.2003.08.011","article-title":"Monoclonal antibodies generated in carbonic anhydrase IX-deficient mice recognize different domains of tumour-associated hypoxia-induced carbonic anhydrase IX","volume":"282","author":"Zat\u2019ovicova","year":"2003","journal-title":"J Immunol Methods"},{"key":"key20180108093016_b8-ol-05-01-0191","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1158\/1078-0432.CCR-04-2019","article-title":"Carbonic anhydrase IX expression predicts outcome of interleukin 2 therapy for renal cancer","volume":"11","author":"Atkins","year":"2005","journal-title":"Clin Cancer Res"},{"key":"key20180108093016_b9-ol-05-01-0191","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1158\/1055-9965.EPI-08-1178","article-title":"Detection of circulating tumor cells in peripheral blood of patients with renal cell carcinoma correlates with prognosis","volume":"18","author":"Bluemke","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"key20180108093016_b10-ol-05-01-0191","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/(SICI)1097-0142(19990801)86:3<492::AID-CNCR18>3.0.CO;2-R","article-title":"The detection of renal carcinoma cells in the peripheral blood with an enhanced reverse transcriptase-polymerase chain reaction assay for MN\/CA9","volume":"86","author":"McKiernan","year":"1999","journal-title":"Cancer"},{"key":"key20180108093016_b11-ol-05-01-0191","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0090-4295(00)00647-6","article-title":"Blood-based RT-PCR assays of MN\/CA9 or PSMA: clinical application in renal cancer patients","volume":"56","author":"de la Taille","year":"2000","journal-title":"Urology"},{"key":"key20180108093016_b12-ol-05-01-0191","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.urology.2005.11.034","article-title":"Detection of carbonic anhydrase-9 gene expression in peripheral blood cells predicts risk of disease recurrence in patients with renal cortical tumors","volume":"67","author":"Gilbert","year":"2006","journal-title":"Urology"},{"key":"key20180108093016_b13-ol-05-01-0191","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.urolonc.2005.10.004","article-title":"Detection of circulating tumor cells in patients with renal cell carcinoma by reverse transcriptase polymerase chain reaction for G250\/MNCA-9: results of a prospective trial","volume":"24","author":"Ohlmann","year":"2006","journal-title":"Urol Oncol"},{"key":"key20180108093016_b14-ol-05-01-0191","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1006\/geno.1996.0223","article-title":"Human MN\/CA9 gene, a novel member of the carbonic anhydrase family: structure and exon to protein domain relationships","volume":"33","author":"Opavsky","year":"1996","journal-title":"Genomics"},{"key":"key20180108093016_b15-ol-05-01-0191","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/sj.bjc.6604111","article-title":"Alternative splicing variant of the hypoxia marker carbonic anhydrase IX expressed independently of hypoxia and tumour phenotype","volume":"98","author":"Barathova","year":"2008","journal-title":"Br J Cancer"},{"key":"key20180108093016_b16-ol-05-01-0191","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.lungcan.2008.10.001","article-title":"Alternative splicing variants of carbonic anhydrase IX in human non-small cell lung cancer","volume":"64","author":"Malentacchi","year":"2009","journal-title":"Lung Cancer"},{"key":"key20180108093016_b17-ol-05-01-0191","article-title":"Splicing variants of carbonic anhydrase IX in bladder cancer and urine sediments","author":"Malentacchi","year":"2010","journal-title":"Urol Oncol"},{"key":"key20180108093016_b18-ol-05-01-0191","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/sj.bjc.6601264","article-title":"Soluble form of carbonic anhydrase IX (CA IX) in the serum and urine of renal carcinoma patients","volume":"89","author":"Zavada","year":"2003","journal-title":"Br J Cancer"},{"key":"key20180108093016_b19-ol-05-01-0191","doi-asserted-by":"crossref","first-page":"510513","DOI":"10.1016\/j.juro.2008.04.024","article-title":"Serum carbonic anhydrase 9 level is associated with postoperative recurrence of conventional renal cell cancer","volume":"180","author":"Li","year":"2008","journal-title":"J Urol"},{"key":"key20180108093016_b20-ol-05-01-0191","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.urology.2009.09.052","article-title":"Quantification of carbonic anhydrase IX expression in serum and tissue of renal cell carcinoma patients using enzyme-linked immunosorbent assay: prognostic and diagnostic potentials","volume":"75","author":"Zhou","year":"2010","journal-title":"Urology"},{"key":"key20180108093016_b21-ol-05-01-0191","first-page":"2953","article-title":"Soluble carbonic anhydrase IX is not an independent prognostic factor in human renal cell carcinoma","volume":"30","author":"Papworth","year":"2010","journal-title":"Anticancer Res"},{"key":"key20180108093016_b22-ol-05-01-0191","doi-asserted-by":"crossref","first-page":"4853","DOI":"10.1158\/1078-0432.CCR-09-3343","article-title":"Biomarkers predicting outcome in patients with advanced renal cell carcinoma: results from sorafenib phase III Treatment Approaches in Renal Cancer Global Evaluation Trial","volume":"16","author":"Pena","year":"2010","journal-title":"Clin Cancer Res"},{"key":"key20180108093016_b23-ol-05-01-0191","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1258\/acb.2010.010240","article-title":"Measuring carbonic anhydrase IX as a hypoxia biomarker: differences in concentrations in serum and plasma using a commercial enzyme-linked immunosorbent assay due to influences of metal ions","volume":"48","author":"Wind","year":"2011","journal-title":"Ann Clin Biochem"},{"key":"key20180108093016_b24-ol-05-01-0191","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1038\/sj.bjc.6602861","article-title":"Ectodomain shedding of the hypoxia-induced carbonic anhydrase IX is a metalloprotease-dependent process regulated by TACE\/ADAM17","volume":"93","author":"Zatovicova","year":"2005","journal-title":"Br J Cancer"},{"key":"key20180108093016_b25-ol-05-01-0191","first-page":"2827","article-title":"Identification of the MN\/CA9 protein as a reliable diagnostic biomarker of clear cell carcinoma of the kidney","volume":"57","author":"Liao","year":"1997","journal-title":"Cancer Res"},{"key":"key20180108093016_b26-ol-05-01-0191","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/j.1464-410X.2007.07006.x","article-title":"Prognostic impact of carbonic anhydrase IX expression in human renal cell carcinoma","volume":"100","author":"Sandlund","year":"2007","journal-title":"BJU Int"},{"key":"key20180108093016_b27-ol-05-01-0191","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/ijc.23496","article-title":"Low CAIX expression and absence of VHL gene mutation are associated with tumor aggressiveness and poor survival of clear cell renal cell carcinoma","volume":"123","author":"Patard","year":"2008","journal-title":"Int J Cancer"},{"key":"key20180108093016_b28-ol-05-01-0191","first-page":"5215","article-title":"Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomas","volume":"61","author":"Wiesener","year":"2001","journal-title":"Cancer Res"}],"container-title":["Oncology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ol.2012.1001\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T10:52:24Z","timestamp":1515408744000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ol.2012.1001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,26]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2012,10,26]]},"published-print":{"date-parts":[[2013,1]]}},"alternative-id":["10.3892\/ol.2012.1001"],"URL":"https:\/\/doi.org\/10.3892\/ol.2012.1001","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,26]]}}}